Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.

Patients with the 5q- syndrome and Diamond-Blackfan anemia (DBA) suffer from a severe macrocytic anemia. The 5q- syndrome and DBA are disorders of aberrant ribosome biogenesis (ribosomopathies) and haploinsufficiency of the ribosomal protein genes RPS14 and RPS19, respectively, underlies the anemia...

Bibliografske podrobnosti
Main Authors:	Boultwood, J, Yip, B, Vuppusetty, C, Pellagatti, A, Wainscoat, J
Format:	Journal article
Jezik:	English
Izdano:	2013

Podobne knjige/članki

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
od: Yip, B, et al.
Izdano: (2013)

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
od: Yip, B, et al.
Izdano: (2013)

Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
od: Yip, B, et al.
Izdano: (2012)

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
od: Yip, B, et al.
Izdano: (2012)

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
od: Yip, B, et al.
Izdano: (2012)

Endocrine responses and acute mTOR pathway phosphorylation to resistance exercise with leucine and whey
od: MT Lane, et al.
Izdano: (2017-02-01)

5q- syndrome.
od: Boultwood, J, et al.
Izdano: (2012)

The mTOR pathway in the antiphospholipid syndrome
od: Ji Lanlan, et al.
Izdano: (2023-12-01)

Comparative study of leucine on digestive enzyme secretion, ISR and mTOR pathway in cattle and porcine pancreas in vitro
od: Zhanhe Zhang, et al.
Izdano: (2024-12-01)

Advances in the 5q- syndrome.
od: Boultwood, J, et al.
Izdano: (2010)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
od: Bello, E, et al.
Izdano: (2018)

The Translational Regulation in mTOR Pathway
od: Miaomiao Yang, et al.
Izdano: (2022-06-01)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
od: Boultwood, J, et al.
Izdano: (2012)

Embryonic Leucine Promotes Early Postnatal Growth via mTOR Signalling in Japanese Quails
od: Sawadi F. Ndunguru, et al.
Izdano: (2024-09-01)

Ursolic acid inhibits leucine-stimulated mTORC1 signaling by suppressing mTOR localization to lysosome.
od: Xiang Ou, et al.
Izdano: (2014-01-01)

Amino acid sensing and mTOR regulation: inside or out?
od: Goberdhan, D, et al.
Izdano: (2009)

The mTOR pathway and integrating immune regulation.
od: Cobbold, S
Izdano: (2013)

The role of the mTOR pathway in diabetic retinopathy
od: Fabio Casciano, et al.
Izdano: (2022-11-01)

Early leucine programming on protein utilization and mTOR signaling by DNA methylation in zebrafish (Danio rerio)
od: Qiang-Sheng Zhu, et al.
Izdano: (2020-08-01)

Abundance of Amino Acid Transporters and mTOR Pathway Components in the Gastrointestinal Tract of Lactating Holstein Cows
od: Qianming Jiang, et al.
Izdano: (2023-03-01)

The TSC-mTOR pathway regulates macrophage polarization
od: Byles, Vanessa, et al.
Izdano: (2015)

Cancer Biogenesis in Ribosomopathies
od: Sergey O. Sulima, et al.
Izdano: (2019-03-01)

Ribosomopathies: Mechanisms of Disease
od: Hani Nakhoul, et al.
Izdano: (2014-08-01)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine.
od: Soumya K Kar, et al.
Izdano: (2017-01-01)

Amino acid primed mTOR activity is essential for heart regeneration
od: Jason W. Miklas, et al.
Izdano: (2022-01-01)

mTOR and cancer: many loops in one pathway
od: Efeyan, Alejo, et al.
Izdano: (2012)

The mTOR pathway controls phosphorylation of BRAF at T401
od: Daniel Christen, et al.
Izdano: (2024-09-01)

Editorial: mTOR pathway malfunctions in neurodevelopmental disorders
od: Xinqi Fang, et al.
Izdano: (2023-01-01)

Targeting the mTOR pathway in Chromophobe Kidney Cancer
od: Brian Shuch, Srinivas Vourganti, Julia C. Friend, Lee M. Zehngebot, W. Marston Linehan, Ramaprasad Srinivasan
Izdano: (2012-01-01)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
od: Erica Bello, et al.
Izdano: (2018-11-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
od: Victor H. Villar, et al.
Izdano: (2017-05-01)

Ribosomopathies: New Therapeutic Perspectives
od: Emilien Orgebin, et al.
Izdano: (2020-09-01)

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
od: Carbonneau, M, et al.
Izdano: (2016)

mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy
od: Anna Gerasimenko, et al.
Izdano: (2023-06-01)

Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
od: Cobbold, S, et al.
Izdano: (2009)

Amino acids control blood glucose levels through mTOR signaling
od: Jialin Fan, et al.
Izdano: (2022-06-01)

mTOR-S6K1 pathway mediates cytoophidium assembly
od: Sun, Z, et al.
Izdano: (2019)

The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification
od: Haitao Wang, et al.
Izdano: (2024-01-01)

mTOR, autophagy and reprogramming
od: Bor Luen eTang
Izdano: (2014-01-01)

The 5q-syndrome.
od: Boultwood, J, et al.
Izdano: (1994)